Rochester, MN - A case report of a patient who suffered erosion of an Amplatzer septal-occluder device (St Jude Medical) six years after it was implanted, resulting in cardiac tamponade and ...
Golden Valley, MN The FDA Circulatory Systems Device Panel has recommended approval of the Amplatzer ® Septal Occluder along with the Amplatzer ® Delivery System for patients with secundum atrial ...
The cardiologist determines what size Amplatzer occluder to use by inflating a small balloon within the defect, and measuring the indentation in the balloon created by the defect. The Amplatzer ...
TCT 195: Percutaneous Patent Foramen Ovale Closure for Migraine with the Amplatzer PFO Occluder: A Pooled Analysis of Individual Participant Data from the Randomized Trials Receive the the latest news ...
ABBOTT PARK, Ill., Aug. 30, 2021 /PRNewswire/ -- Abbott (NYSE: ABT) today announced late-breaking data from the Amulet™ LAA Occluder IDE trial, a multi-center, head-to-head study comparing the company ...
First and only steerable delivery system designed to help seal the left atrial appendage (LAA) in people with atrial fibrillation who are at an increased risk of stroke Now available in the U.S., ...
New Guidelines Issued for Management of Atrial Fibrillation The Amulet device is designed for complete immediate closure of the left atrial appendage using dual-seal technology. Using dual-seal ...
TCT 116: Peri-device leaks following transcatheter left atrial appendage occlusion with the Amplatzer devices: Correlation between cardiac CT and transesophageal echocardiography Receive the the ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback